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The infrarenal abdominal aorta and the iliac arter-
ies are among the most common sites of atherosclero-
sis in patients with symptomatic chronic lower extrem-
ity ischemia. Treatment of aortoiliac disease can be 
categorized as anatomic or direct reconstructive pro-
cedures on the aortoiliac vessels, extra-anatomic or
indirect bypass grafts that avoid normal anatomic path-
ways, and nonoperative catheter-based percutaneous
endoluminal therapies.1 The first reports of successful
balloon angioplasty for abdominal aortic stenosis were
from Velasquez et al2 and Grollman et al3 in 1980 and
Hudon et al4 in 1982. Since then, many centers
reported their experiences with technical and initial
success rates that varied from 66% to 100%. However,
little information is available on long-term patency
after this procedure. From May 1980 to November
1997, 46 consecutive patients underwent percuta-
neous transluminal angioplasty (PTA) for symptomatic
chronic atherosclerosis stenosis of the lower abdominal
aorta at the Montreal Heart Institute. We present the
early and long-term clinical and hemodynamic results
of these cases. 
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Purpose: The purpose of this study was to determine the early and long-term results of
percutaneous transluminal angioplasty (PTA) of atherosclerotic lower abdominal aorta
stenosis.
Methods: This study was performed as a retrospective study. From 1980 to 1997, 46
patients with chronic lower limb ischemia with moderate to severe claudication as the
result of isolated infrarenal disease or aortoiliac disease underwent PTA. All patients
underwent angiography before and after angioplasty and Doppler ultrasound scan
examination with ankle-brachial index determination. No stents were used.
Results: The technical success rate was 96% (44 of 46 cases). Thirty-eight patients (83%)
immediately showed clinical, hemodynamic, and angiographic improvement. The initial
success rate for patients with isolated infrarenal or bifurcation disease was 92%, where-
as it was 71% for aortoiliac disease. Among the eight patients with no initial improve-
ment, four had clinical deterioration and two required emergency surgical revasculariza-
tion. There were no other complications. Fifty-six percent of the patient conditions (95%
confidence interval [CI], 38% to 74%) remained clinically improved at the 5-year follow-
up examination. Recurrence of symptoms was caused by femoropopliteal disease in most
patients. The primary patency rate assumed with maintenance of hemodynamic improve-
ments was 70% (95% CI, 52% to 88%) and 64% (95% CI, 44% to 84%) at 4 and 5 years
of follow-up, respectively. The primary patency rate at 4 years for patients with isolated
infrarenal or bifurcation disease was 83% (95% CI, 64% to 100%), whereas it was 55%
for aortoiliac disease (95% CI, 30% to 80%; P = .06) The variables that were statistical-
ly predictive of patency failure were poor runoff (P = .01) and presence of aortoiliac ath-
erosclerotic disease (P = .04).
Conclusion: Our results suggest that PTA is an excellent treatment for chronic arterial
insufficiency of the lower extremities as the result of isolated atherosclerotic lower
abdominal aortic occlusive lesions because of good long-term patency. Aortic PTA for
those patients with iliac involvement or with poor runoff gives acceptable results but
carries lower patency and clinical success rates. (J Vasc Surg 1999;30:679-92.)
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MATERIAL AND METHODS
We performed a retrospective review of all 46
patients who underwent PTA of the lower abdomi-
nal aorta from May 1980 to November 1997 at our
institution. Age, sex, and risk factor distributions are
reported in Table I.
Patient selection. For every patient, a written
medical history and a physical examination were
obtained and peripheral vascular disease was clinical-
ly evaluated according to Fontaine classification.5
No patient was excluded on the basis of significant
concurrent illness. All the PTAs were performed for
moderate to severe claudication, and there was no
case of acute lower limb ischemia or blue toe syn-
drome. All the patients underwent noninvasive eval-
uation before angiography and PTA, with determi-
nation of resting ankle-brachial index (ABI; 46 of 46
cases) and lower extremity Doppler scan waveform
analysis at five arterial levels (45 of 46 cases).6-8
Unfortunately, no patients underwent treadmill
exercise testing. Diagnostic angiography of the
abdominal aorta and both lower extremities was per-
formed before the procedure on a long leg serial film
changer (BC Medical, Montreal, Canada).9 This
conventional cut-film angiogram was used to mea-
sure and localize the abdominal aortic stenosis, eval-
uate the arterial run-off, define the reference aortic
diameter, and select the proper balloon diameter. All
the patients had short-length (2 cm) or medium-
length (2 to 4 cm) chronic atherosclerotic stenosis
of the infrarenal abdominal aorta (category 1 or 2
lesions).5 No patients had aortic occlusion or aortic
stenosis associated with Takayasu’s arteritis. Stenosis
associated with aneurysmal infrarenal aorta was con-
sidered a contraindication to aortic angioplasty, and
eccentric and calcified lesions were treated with
extreme caution, avoiding overdilatation because of
the risk of aortic wall rupture. Runoff was classified
as poor if the femoropopliteal segment contained a
stenosis >50%. Nineteen patients in this series had a
poor runoff. PTAs and initial angiogram were per-
formed in different sessions.
Procedure
Informed consent was obtained from all the
patients. No routine surgical consultations were
requested. All the procedures were performed with
local anesthesia by the transfemoral route by two expe-
rienced radiologists (G.H., L.L.), either on an outpa-
tient or a 24-hour admission basis. In each patient,
intra-arterial pressures were measured proximally and
distally to the stenosis, and a gradient before angio-
plasty was determined. No vasodilators were used,
except in one case (60% stenosis with a gradient of
54/5 mm Hg after 30 mg papaverine hydrochloride).
During the course of 17 years, the quality of the per-
cutaneous balloon catheters improved constantly, and
thus, several types (vinyl choloride polymer and poly-
ethylene terephthalate) of different sized (6 mm to 15
mm)2,3 balloon catheters from several different manu-
facturers (Cook, Meditech, Bard/USCI, Cordis,
VasCath, Mansfield) were used. Pressure gauges were
used with the maximum inflation pressure being kept
within the range specified by the manufacturers, vary-
ing from 3 to 10 atm. No stretching pain and minimal
discomfort were tolerated. All the lesions were
approached from the groins. Until the commercial
availability of larger balloon sizes (10 to 15 mm), the
two-balloon “kissing technique” was used.2,3 A single
balloon was used in 36 cases (75%). No stent was used.
Postangioplasty gradient was again obtained, and a
single plane arteriogram was performed to determine
residual stenosis.
Follow-up examination
An antiplatelet regimen was started 48 hours
before PTA and continued for at least 3 months (50
mg dipyridamole and 650 mg acetylsalicylic acid
between 1980 and 1984, and 325 mg acetylsalicylic
acid daily thereafter). For patients who underwent
treatment between 1980 and 1984, follow-up was
standardized at 1, 6, 12, and 24 months after PTA.
For patients who underwent treatment after 1984,
follow-up was performed 1 to 2 months after the
procedure and if symptoms recurred. For most of
the patients with initial success (36 of 38 patients;
95%), follow-up was updated between January 1995
Table I. Patient’s characteristics
Characteristics No. of patients
Sex
Male 19 (41%)
Female 27 (59%)
Age (years)*
39 to 50 12 (26%)
51 to 60 13 (28%)
61 to 70 15 (33%)
≥71 6 (13%)
Smoking 35 (83%)
Coronary disease 31 (79%)
Dyslipidemia 25 (63%)
Hypertension 13 (32%)
Diabetes 14 (35%)
Type 2 12 (30%)
Type 1 2 (5%)
Obesity 8 (21%)
*Mean age ± SD, 58 ± 11 years; age range, 39 to 81 years.
and November 1997 with clinical status evaluation,
noninvasive examination, and angiography if indi-
cated. In two patients, information about clinical
status and noninvasive examination was obtained
through their family physician. Two patients who
lived more than 200 km from our hospital were lost
to follow-up.
Definition of success/failure. A combination
of clinical, hemodynamic, and angiographic factors
was necessary to determine early success.10-12
Clinical improvement was defined as the sympto-
matic improvement of at least one Fontaine class.5
Hemodynamic improvement was defined as a mini-
mal increase in ABI of 0.10. In a few cases, ABI were
artifactually elevated because of mediocalcinosis or
normal because of mild stenosis. The improvement
of common femoral arteries Doppler scan wave-
forms was used as criteria of hemodynamic improve-
ment either with normalization of a previously
monophasic Doppler scan velocity waveform or with
improvement of an abnormal waveform (higher sys-
tolic peak, sharper systolic upstroke, and decreased
flow velocity time).13-17 Angiographic success meant
<30% residual stenosis.
Late success necessitated the maintenance of ini-
tial clinical improvement and primary patency.
Patency was assumed with no residual angiographic
stenosis (in the few cases in which late angiography
was done; ie, 9 patients) and with preservation of ABI
improvement (maintenance of ABI improvement at
least 0.10 above the preoperative index with no more
than 0.15 deterioration at follow-up) or normal com-
mon femoral arteries Doppler scan waveforms.10-17
This last criterion avoided femoropopliteal disease
being mistaken for aortic restenosis. The last nonin-
vasive examination or aortography recorded was used
as the latest follow-up for the patency and cumulative
success life-table analysis. The last clinical evaluation
was used as the latest follow-up for the clinical
improvement life-table analysis. The failure dates of
recurrent stenosis or clinical deterioration were
recorded halfway between the last two examination
points. Any other PTA or surgery in between was
noted. Patients who had initial failure immediately
after their angioplasty were included in life-table
analysis. Results are expressed as the mean ± the stan-
dard deviation. Statistical analysis was made with
paired t test or χ2 test to compare ABIs or gradients.
The Kaplan-Meier product limit method was used to
estimate the overall cumulative success, clinical, and
patency rates during the time of follow-up (with 95%
confidence interval [CI]). The log-rank test was used
to compare cumulative patency rates for isolated aor-
tic or bifurcation diseases and aortoiliac disease.
Univariate logistic regression followed by multivariate
stepwise regression keeping all factors with a P value
of less than .15 was used for analysis of the multiple
determinants of preserved patency for categorical vari-
ables. Results were considered statistically significant
if the P value was less than .05.
RESULTS
Preangioplasty status. Forty-six patients
(100%) had chronic lower limb arterial insufficiency
attributed to aortic stenosis. All the patients had
moderate to severe claudication (Fontaine II-b),
except for one patient with rest pain (Fontaine III).
One patient had atypical pain interpreted as moder-
ate claudication and erectile dysfunction attributed
to his aortic stenosis. This patient had a 60% aortic
stenosis with a gradient of 38/11 mm Hg.
All the patients had ABI determination before
angioplasty (46 of 46 cases). The mean ABI was 0.77
± 0.16 and 0.74 ± 0.15 on the right and left sides,
respectively. Four ABI results (4 of 46 cases) were not
included in the mean calculation because of discor-
dance between them and the flow velocity as a result
of mediocalcinosis. Ten other patients (10 of 42 cases)
had at least one ABI of more than 0.95 before treat-
ment (12 of 84 ABIs >0.95; 2 of 42 patients with both
ABIs >0.95). All of these patients had typical claudica-
tion symptoms. Unfortunately, these patients did not
have treadmill exercise testing, which would have pro-
vided good objective evidence of their claudication.
However, Doppler scan waveform analysis revealed
hemodynamic abnormalities on common femoral
arteries for eight of the patients (8 of 10: lower or
delayed systolic peak, flatter systolic upstroke, no
reverse flow, increase flow velocity time) and was used
to assess hemodynamic improvement after PTA. Two
patients (2 of 10) had ABIs of more than 0.95 with
normal Doppler scan waveform analysis. These
patients had stenosis of 55% to 60% with significant
gradient. Their conditions were improved clinically as
their gradient was abolished. Hemodynamic improve-
ment was assumed for these two patients because their
ABIs and Doppler scan femoral waveform analyses did
not become abnormal.
Angiograms were obtained on all patients: 19
patients (41%) had stenosis confined to the
infrarenal aorta without bifurcation or iliac disease,
six (13%) had aortic stenosis within 2 cm of the aor-
tic bifurcation, and 21 (46%) had stenosis on the
infrarenal aorta with significant atherosclerotic dis-
ease involving the iliac arteries (defined as lesions
>30%). One patient with a previous aortoiliac graft
JOURNAL OF VASCULAR SURGERY
Volume 30, Number 4 Elkouri et al 681
JOURNAL OF VASCULAR SURGERY
682 Elkouri et al October 1999
had severe claudication because of a 60% aortic
stenosis proximal to the graft with a measured gra-
dient of 48/9 mm Hg. This was not an anastomot-
ic stenosis, and there was no stenosis on the graft
itself. Of the 21 patients with aortoiliac disease, five
underwent simultaneous iliac and aortic PTA (four
common iliac PTAs, and one external iliac PTA) and
four patients already had undergone an iliac PTA
before the aortic PTA. Stenoses were less than 2 cm
in length in 37 patients (80%) and 2 to 4 cm in nine
patients. Stenoses were eccentric in 27 patients
(59%). Five patients had calcified stenosis (11%).
Mean angiographic stenosis was 67% ± 12% as mea-
sured from single plane conventional angiogram on
cut films. Mean systolic and diastolic gradients were
36 mm Hg ± 20 mm Hg and 5 mm Hg ± 4 mm Hg.
Early results. Early success was judged with a
combination of clinical, hemodynamic, and angio-
graphic factors from all the 46 patients.
Thirty-eight patients (83%) had conditions that
were clinically and hemodynamically improved, and
most of them were asymptomatic (n = 29). Four
patients (9%) reported no clinical improvement.
Four patients (9%) reported clinical deterioration,
and two of those patients required surgery within 1
week after the procedure. The initial success rate for
patients with isolated infrarenal or bifurcation dis-
ease was 92%, whereas it was 71% for aortoiliac dis-
ease (P < .05).
Mean ABI, as reported in Table II, was signifi-
cantly increased when compared with the preangio-
plasty results (P < .00001). The proportion of
patients with ABIs more than 0.95 increased from
14% (6 of 42 cases) to 74% (31 of 42 cases) and from
14% (6 of 42 cases) to 69% (29 of 42 cases) for the
right and left sides, respectively. The mean ABI
increase for patients with initial ABIs of less than
0.95 and successful procedures was 0.23 and 0.24 for
the right and left sides, respectively. Of the 38
patients with initial success, nine patients still had at
least one abnormal ABI (0.55 to 0.91), which
improved or remained stable at late follow-up exam-
ination. Two of these patients had clinical deteriora-
tion at late follow-up examination. Of the 45 prean-
gioplasty Doppler scan waveforms, four results were
normal and 41 results were abnormal (91%). Of
these 41, 31 conditions improved after treatment
(76%) and 27 of the conditions became healthy
(68%). Seventy-six percent of these 27 remained
healthy in the long term. Improvement in 31 of the
41 abnormal common femoral artery Doppler scan
waveforms was associated with ABIs increasing ini-
tially, except in one case. Postangioplasty gradients
were significantly diminished when compared with
preangioplasty values (P < .00001). Forty patients
(40 of 46) had no arterial gradient after the proce-
dure. One patient had a 30–mm Hg gradient after
the procedure and reported clinical deterioration.
Mean postangioplasty angiographic stenosis was 20%
± 17%. Simultaneous common iliac and aortic PTA
were performed on four patients. There were no
major complications during the procedure other than
one balloon rupture. Two patients needed surgical
intervention for acute lower limb ischemia as the
result of external iliac artery thrombosis. No other
complications occurred. Most of the patients (93%)
remained at the hospital for less than 48 hours.
The initial failure rate was 17%. The technical
success rate was 96%: one stenosis could not be
crossed from both femoral arteries, and one patient
had a residual gradient of 30 mm Hg after PTA.
Both patients had aortoiliac disease. One patient had
excellent immediate results after 75% stenosis PTA
with abolition of a 70–mm Hg gradient and ABIs
and Doppler scan waveform analysis normalization
but had a right external iliac artery thrombosis less
than 24 hours after the PTA and required emergent
thrombectomy as mentioned previously. Of the five
Table II. Results of ankle-brachial index measures
Before angioplasty Initial results Late results
42 of 46 cases 42 of 46 cases 33 of 38 cases
Ankle-brachial index Right Left Right Left Right Left
>0.95 14% 14% 74% 69% 45% 45%
0.85 to 0.95 17% 10% 12% 5% 24% 24%
0.75 to 0.85 24% 27% 2% 7% 15% 12%
0.65 to 0.75 23% 22% 2% 10% 9% 6%
0.55 to 0.65 14% 19% 2% 7% 3% 6%
<0.55 7% 7% 7% 2% 3% 6%
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other patients, four had significant aortoiliac disease
and their ABIs and Doppler scan waveform analyses
did not improve despite technical success (no resid-
ual stenosis or gradient). Therefore, of the eight
patients with initial failure, seven had lower limb
atherosclerotic disease, six had aortoiliac disease, and
three had diabetes. Only two of these patients had
iliac angioplasty (one 2 months before PTA and one
simultaneous to aortic PTA).
Late results/life-table analysis. The median
follow-up time for the 38 successfully treated patients
was 44 months (range, 1 to 204 months; mean, 50
months). Four patients had loss of patency at 7, 30,
48, and 55 months. They all had symptom recur-
rence with ABIs and common femoral arteries wave-
form deterioration. They all had type 2 diabete.
Angiographic results showed severe atherosclerotic
disease with 50% stenosis, 90% stenosis, and occlu-
sion at the site of aortic angioplasty between the ori-
gin of the inferior mesenteric artery and the aortic
bifurcation, and one patient had no aortic stenosis
but severe external iliac artery atherosclerosis causing
Doppler scan waveforms and ABI deterioration. This
last patient could not undergo treatment with PTA
and was referred to a vascular surgeon for follow-up
examination. One patient had aortobifemoral bypass
grafting performed, whereas two patients had severe
heart conditions precluding surgery. Six patients
underwent iliac PTA during the years after aortic
PTA. Six other patients had clinical deterioration
caused by femoropopliteal disease. No patients
exhibited rest or nocturnal pain. No patients
required amputation. The five patients who under-
went combined aortic and iliac PTA had preserved
patency at follow-up examination. Interestingly, one
patient is still asymptomatic with preserved patency
17 years after the angioplasty without any additional
vascular procedure needed.
Overall cumulative success, clinical improve-
ment, and patency rates are reported in Figs 1 to 3.
The results are expressed according to the total
number of patients (n = 46). At 5 years of follow-up,
the cumulative success rate assumed with mainte-
nance of clinical improvement and preserved paten-
cy was 52% (95% CI, 34% to 70%) and the cumula-
tive clinical improvement rate was 56% (95% CI,
38% to 74%). The primary patency rate assumed
with maintenance of hemodynamic improvements
was: at 1 year, 80% ± 6%; at 3 years, 76% ± 7%; at 4
years, 70% ± 9%; and at 5 years, 64% ± 10% (95% CI,
44% to 84%). The difference between the cumulative
patency rate and the cumulative success rate at 5
years is caused by the progression of distal disease
because six patients had recurrence of symptoms
with normal common femoral artery Doppler scan
waveforms and distal arterial segments waveform
anomalies.
The primary patency rate at 4 years for patients
with isolated infrarenal or bifurcation disease was
83% (95% CI, 64% to 100%), whereas for aortoiliac
Fig 1. Cumulative success life-table analysis (dotted line when standard error exceeds 10%). 
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disease it was 55% (95% CI, 30% to 80%; P = .06).
When initial failures were excluded, the log-rank test
P value between these two groups was .54.
Univariate logistic regression results to deter-
mine predictors of patency failure are reported in
Table III. Variables statistically predictive of patency
failure were poor runoff (P = .01) and presence of
aortoiliac atherosclerotic disease (P = .04). Age,
Fig 2. Cumulative clinical improvement life-table analysis (dotted line when standard error
exceeds 10%).
Fig 3. Cumulative primary patency life-table analysis (dotted line when standard error exceeds
10%).
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male sex, and diabetes appeared also to be predictive
of patency failure, although they did not reach sta-
tistical significance.
DISCUSSION
Surgical treatment of aortoiliac atherosclerotic
disease has greatly evolved since the first aortoiliac
bypass graft in 1950.18 Many options are available.19
The direct reconstructive procedures include
endarterectomy and aortobifemoral bypass grafting.
Aortoiliac endarterectomy, although technically
more demanding, gives excellent and durable results
for patients with localized nonaneurysmal disease
with preferably minimal extension to the external
iliac arteries. Inahara20 reported an 11-year cumula-
tive patency rate of 86% and a low operative mortal-
ity rate (3%). Most of the failures were associated
with small vessel disease either in women or in men
of small physical size.20 Aortobifemoral bypass graft-
ing remains the gold standard in the treatment of
aortoiliac disease. Its wide applicability to most pat-
terns of aortoiliac disease and its well-documented
patency rates of 85% to 90% at 5 years and 75% to
80% at 10 years explain its success. Operative mor-
tality for this procedure varies from 1% to 5%, with
major complications occurring in 5% to 10% of
patients. Late morbidity associated with aorto-
bifemoral bypass grafting includes impotence and
other sexual dysfunction in 11% to 33% of patients
and graft infection in 1.8% to 4%. Other late com-
plications include anastomotic pseudoaneurysms
and the rare aortoduodenal fistula. Catheter-based
endoluminal methods, such as PTA, can sometimes
be an adjunct or an alternative to the surgical treat-
ment. Their use in the treatment of atherosclerotic
disease dates back to 1964 when Dotter and
Judkins21 described the first angioplasties performed
in the femoropopliteal system with coaxial catheters
up to 12F in diameter. Since the first report in 1980
of a successful PTA of the lower abdominal aorta,
many series were published with this procedure,
with this one being the largest to date.
A direct comparison of the available data on
these different therapeutic options is difficult, partly
because of the differences in clinical indication and
pattern of aortoiliac disease treated. The results
depend on the type, localization, and extent of the
disease treated as well. Variations in results can also
be explained by differences in study design and def-
inition of patency. For example, iliac PTA 5-year
cumulative patency rates vary from 32% to 92%.1
The following four key variables were shown by
Johnston et al22,23 to accurately predict the chance
of iliac PTA long-term success: indication, site,
severity, and run-off.
The potential advantages of percutaneous treat-
ments, including reduced morbidity and mortality,
reduced hospital stays, quicker recovery, and proba-
ble cost advantages, explained the attractiveness of
these less invasive procedures over traditional surgi-
cal treatment. Percutaneous procedures also do not
carry the inherent risks of general anesthesia.
However, they appear less durable than bypass grafts
and are generally less broadly applicable to most
patients with extensive aortoiliac atherosclerosis.1
Several authors have suggested that PTA should
be considered the treatment of choice over surgical
intervention for the unusual symptomatic focal ath-
erosclerotic stenosis of nonaneurysmal abdominal
aorta. The association between localized occlusive
disease of the distal abdominal aorta and small-cal-
iber vessels has long been recognized in women.24-28
DeLaurentis et al26 described such a group and
labelled it the “hypoplastic aortoiliac system.”26
These patients are generally younger and are consis-
tently heavy smokers. It is unclear whether they rep-
resent a distinct subgroup with premature atheroscle-
rosis or whether the symptoms just develop earlier in
life because of the smallness of their vessels. We sum-
marized the experience of the French and English 
literature on initial and long-term success rate of PTA
of the infrarenal aorta in Table IV.4,29-38,45-54
Charlebois et al,29 Johnston et al,30 Belli,31 Hallisey
et al,32 Sagic et al,47 and Joosten et al33 reported
Table III. Results of univariate logistic regression analysis for predictors of patency
Dependent Predictor β ± SEM OR 95% CI of OR P value
Patency Runoff 1.97 ± 0.77 7.2 [1.61; 32.29] .01
Patency Extent of disease 1.53 ± 0.73 4.6 [1.11; 19.14] .04
Patency Diabetes 1.17 ± 0.71 3.2 [0.81; 12.91] .09
Patency Sex –1.07 ± 0.69 0.34 [0.09; 1.32] .12
Patency Age 0.06 ± 0.04 1.97 [0.95; 4.08] .07
OR, Odds ratio; CI, confidence interval.
their experiences with patients with mostly focal
infrarenal stenosis.29-33 Interestingly, in these reports
and in the present study, most patients were women
(87 of 109 patients). The high prevalence of smok-
ing (83%) and coronary disease (79%) is also impres-
sive. PTA of the lower abdominal aorta for these
patients achieves good results, with reported initial
success rates varying from 95% to 100% (92% in 
the present study) and 5-year symptom-free success
rates varying from 70% to 89%. However, long-
JOURNAL OF VASCULAR SURGERY
686 Elkouri et al October 1999
Table IV. Reports on percutaneous transluminal angioplasty of the abdominal aorta
Authors Year No. of cases Extent of disease Technical success rate
Hudon et al4 1982 2 Infrarenal aorta 100%
Heeney et al49 1983 6 Infrarenal aorta, sb and db 83%
Tegtmeyer et al36 1985 32 56 aortic bifurcations, 94%
3 infrarenal aortas, db
Charlebois et al29 1986 14 11 infrarenal aortas (length, 100%
5 to 13 mm) sb and db
Courthéoux et al50 1986 8 Infrarenal aorta or aortic bifurcation, db 100%
Morag et al46 1987 14 7 infrarenal aortas, 7 aortic bifurcations 86%
with common iliac
Belli et al31,51 1988 13 13 infrarenal aortas, sb and db 100%
Tadavarthy et al52 1989 1 Aortic bifurcation, db —
Yakes et al34 1989 32 16 infrarenal aortas, 4 if + iliac stenoses, 100%
12 aortoiliac diseases (length, 19, <2 cm; 100%
6, 2 to 4 cm; 7, >4 cm) sb, db, and tb
Odurny et al37 1989 25 14 infrarenal aortas, 7 aortic bifurcations, 
4 diffuse infrarenal aortas, sb or db 100%
Gross-Fengels et al53 1990 12 7 infrarenal aortas, 5 if + iliac stenosis 100%
El Ashmaoui et al45 1991 20 12 infrarenal aortas, 8 aortoiliac, sb, db, and stent 100%
Ravimandalam et al35 1991 27 5 infrarenal aortas, 19 aortic bifurcations ± iliac 93%
diseases, sb and db
Morag et al38 1993 28 13 infrarenal aortas, 15 aortic bifurcations, sb and db 96%
Hallisey et al32 1994 14 14 infrarenal aortas (length, 100%
3 to 21 mm) sb, db, and 3 stents
Steinmetz et al54 1994 8 Infrarenal aorta, db 88%
Sagic et al47 1995 14 6 aortic bifurcations, —
8 aorto-iliac, db
Joosten et al33 1996 38 38 infrarenal aortas, sb and db 95%
Elkouri et al 1998 46 19 infrarenal aortas, 6 aortic bifurcations, 21 aortoiliac, 96%
sb and db
*Not actuarial.
†17 patients of the 25 included in the cumulative patency analysis, patency based on clinical and hemodynamic data, and in life-table 
analysis prospective.
‡State of the femoral pulse used to determine patency, with life-table analysis.
§Absence of clinical deterioration used to define patency, not life-table analysis, excluding initial failure.
Isolated infrarenal or bifurcation disease, 92%. Aortoiliac disease, 71%.
¶Isolated infrarenal or bifurcation disease, 4 years, 83%. Aortoiliac disease, 4 years, 55%.
sb, Single balloon; db, double balloon; tb, triple balloon; NA, not available; th, thrombosis; emb, embolus; if, infrarenal; ABI, ankle-brachial index.
term patency rates are difficult to estimate because
life-table analyses are absent from most of the small
series published on the subject. Yakes et al34 and
Ravimandalam et al35 each reported their experiences
with patients with stenosis of the infrarenal aorta with
or without aortic bifurcation and iliac artery involve-
ment. They reported good results with initial success
rates of 93% and 100%. However, some of these
patients were not claudicant but underwent treat-
ment for impotence or blue-toe syndrome. Mean fol-
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low-up examinations at 22 months and 25 months
were reported, but patency rates were not recorded
in these two series. Tegtmeyer et al36 reported their
experience with stenosis of the aortic bifurcation with
the “kissing balloon technique” in 32 patients, with
a 90% patency rate at 1 year. Dilation of stenosis
more than 4 cm in length has been reported by Yakes
et al34 in seven patients, with no deterioration in six
of the patients after a mean follow-up period of 36
months (range, 4 to 78 months).
In a well-designed prospective study, Odurny et
al37 estimated at 70% the 5-year cumulative patency
rate of aortic angioplasty, which is similar to our
results. Morag et al38 also reported a cumulative
patency rate of 89% at 2 years. However, differences
in patency definition preclude a direct comparison of
their results with ours. PTA has also been used to
treat patients with aortic occlusion. Iyer et al39 and
Pilger et al40 reported their experiences in 25
patients with the use of balloon angioplasty after
Initial success rate Mean follow-up period Patency rate Major complications
100% 18 months 100% No complications
66% Range, 3 to 6 months NA 1 deterioration followed by aortoiliac
bypass grafting
94% 14 months (range, 1 to 53 months) 90%* 2 iliac th, 1 pseudoaneurysm,
1 groin hematoma
93% 16 months (range, 1 to 58 months) NA Balloon rupture, 1 iliofemoral th
88% NA NA No complications
86% 3 years (range, 1 to 5 years) NA 1 iliac th, 1 groin hematoma, 1 peripheral emb
100% 27 months (range, 7 to 70 months) NA No complications
— 108 months patent —
100% 25 months (range, NA 1 death after myocardial infarction
1 to 96 months)
94% 33 months 2 years, 80%; 1 limb ischemia
5 years, 70%†
— — NA No complications
100% Median 15 months (range, NA 1 groin hematoma
3 to 35 months)
93% Range, 3 to 48 months NA 1 common iliac th, 1 superficial femoral th, 
2 bleedings, 1 infection at puncture site
NA 4.5 years (range, 1 to 9 years) 2 years, 89%‡ 1 iliac th, 1 peripheral emb, 2 groin hematomas
100% 52 months (range, 1 to 118 months) 93%§ No complications
88% 13 months NA 1 deterioration of ABI
85% 47 months (range, 6 to 143 months) 79%* 1 iliac th
94% 34 months (range, 1 to 92 months) NA 2 iliac dissections
83% 30 months (median, 44 months; range, 4 years, 70% 2 iliac th
1 to 204 months) 5 years, 64%
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thrombolytic treatment in patients with claudication
as the result of chronic occlusion of the aortic bifur-
cation. These patients had localized aortoiliac dis-
ease with occlusive lesions confined to the distal
aorta or the common iliac arteries or both. They
achieved clinical improvement with significant ABI
increase in 13 of their patients and without recur-
rence at a mean follow-up of 21 months (range, 6 to
36 months). Diethrich41 also reported the successful
use of thrombolysis followed by PTA and stent
implantation in seven patients with severely sympto-
matic abdominal aortic occlusions.
Few authors report the combined implantation
of stent after aortic angioplasty on the basis of
whether post-PTA angiography reveals important
irregular calcifications of the stenotic lesion (when
further dilatation could lead to aortic rupture as
described by Berger et al48) associated with signifi-
cant residual stenosis and gradient or medial dissec-
tion.41-44 Although the experience with aortic stent
is limited, the results obtained thus far suggest that
the procedure is safe and effective.
Complications related to PTA are infrequent and
generally minor. Acute lower limb ischemia caused
by iliac thrombosis29,35,36,38,46,47 or dissection,33
distal embolization with limb loss35 and aortic rup-
ture48 in a patient with a concentric calcified plaque
have been reported.
Our initial success rate seems lower than those
reported in many series but compares well with the
few series with similar proportions of aortoiliac dis-
ease treated.45,46 The initial failure rate was higher
when treating aortoiliac disease as compared with
isolated aortic or bifurcation stenosis. This probably
explains the tendency toward statistically significant
differences (P = .06) when comparing these two
groups’ 4-year patency rates because reanalysis
excluding initial failures was clearly not statistically
significant (P = .54). Poor runoff was also predictive
of patency failure as indicated by multivariate step-
wise regression.
Our late success rates, clinical improvement
rates, and patency rates include initial failure. When
excluding initial failure, the patency rates were: at
1 year, 97% ± 3%; at 3 years, 92% ± 6%; at 4 years,
85% ± 8%; and at 5 years, 77% ± 11%, among initial
successes.
In conclusion, this retrospective study supports
the use of PTA in the treatment of infrarenal abdom-
inal aortic stenosis. The procedure has a low mor-
bidity and mortality and achieves good long-term
primary patency, especially for isolated aortic or
bifurcation stenosis. However, PTA appears less suit-
able for patients with more extensive aortoiliac dis-
ease or poor runoff but, in specific circumstances,
such as poor surgical candidates or young patients,
can still be a good alternative to surgery when ini-
tially successful. However, the limited literature on
the combined aortic and iliac PTA does not permit
to weaken or confirm these premises with certainty.
Further studies will be necessary to substantiate
these potential benefits.
We thank France Giroux for technical assistance,
France Thériault and Caroll Boyer for preparation of the
manuscript, and Jean Lambert and André Couturier for
statistical assistance.
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APPENDIX 1
Cumulative success life-table analysis
Cumulative primary
Month of failure No. of patients No. of failures Failure rate Success rate patency rate (%) Standard error (%)
0 46 8 0.17 0.83 83 6
1 36 0 0 1 83 6
6 30 1 0.03 0.97 80 6
12 29 0 0 1 80 6
18 26 0 0 1 80 6
22 24 1 0.04 0.96 77 7
23 23 1 0.04 0.96 74 7
28 20 2 0.1 0.9 66 8
30 18 0 0 1 66 8
38 17 1 0.06 0.94 62 9
42 15 1 0.07 0.93 58 9
48 10 0 0 1 58 9
56 10 1 0.1 0.9 52 10
72 8 0 0 1 52 10
84 6 0 0 1 52 10
99 5 1 0.2 0.8 42 12
175 3 1 0.33 0.67 28 14
180 2 0 0 1 28 14
204 1 0 0 1 28 14
APPENDIX 2
Cumulative clinical improvement life-table analysis
Cumulative primary
Month of failure No. of patients No. of failures Failure rate Success rate patency rate (%) Standard error (%)
0 46 8 0.17 0.83 83 6
1 36 0 0 1 83 6
6 33 1 0.03 0.97 80 6
12 32 0 0 1 80 6
18 29 0 0 1 80 6
22 28 1 0.04 0.96 78 6
23 26 1 0.04 0.96 75 7
24 24 0 0 1 75 7
28 23 2 0.09 0.91 68 8
30 21 0 0 1 68 8
36 20 0 0 1 68 8
38 20 1 0.05 0.95 65 8
42 18 1 0.06 0.94 61 8
48 13 0 0 1 61 8
54 12 0 0 1 61 8
56 12 1 0.08 0.92 56 9
60 11 0 0 1 56 9
66 9 0 0 1 56 9
99 6 1 0.17 0.83 47 11
175 3 1 0.33 0.67 31 15
204 1 0 0 1 31 15
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APPENDIX 3
Cumulative primary patency life-table analysis: aortoiliac disease
Cumulative primary
Month of failure No. of patients No. of failures Failure rate Success rate patency rate (%) Standard error (%)
0 21 6 0.29 0.71 71 10
1 14 0 0 1 71 10
2 14 0 0 1 71 10
6 14 0 0 1 71 10
7 14 1 0.07 0.93 66 10
12 13 0 0 1 66 10
18 11 0 0 1 66 10
30 11 0 0 1 66 10
42 10 0 0 1 66 10
48 6 1 0.17 0.83 55 13
54 5 0 0 1 55 13
60 4 0 0 1 55 13
62 3 0 0 1 55 13
84 3 0 0 1 55 13
96 2 0 0 1 55 13
108 2 0 0 1 55 13
111 1 0 0 1 55 13
180 1 0 0 1 55 13
APPENDIX 4
Cumulative primary patency life-table analysis: aortic and bifurcation diseases
Cumulative primary
Month of failure No. of patients No. of failures Failure rate Success rate patency rate (%) Standard error (%)
0 25 2 0.08 0.92 92 5
1 21 0 0 1 92 5
2 16 0 0 1 92 5
6 15 0 0 1 92 5
12 15 0 0 1 92 5
18 13 0 0 1 92 5
30 10 1 0.1 0.9 83 10
42 8 0 0 1 83 10
48 7 0 0 1 83 10
54 6 0 0 1 83 10
55 6 1 0.17 0.83 69 15
60 5 0 0 1 69 15
62 5 0 0 1 69 15
84 3 0 0 1 69 15
96 3 0 0 1 69 15
108 3 0 0 1 69 15
120 2 0 0 1 69 15
180 2 0 0 1 69 15
204 1 0 0 1 69 15
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APPENDIX 5
Cumulative primary patency life-table analysis (all patients)
Cumulative primary
Month of failure No. of patients No. of failures Failure rate Success rate patency rate (%) Standard error (%)
0 46 8 0.17 0.83 83 6
1 35 0 0 1 83 6
2 30 0 0 1 83 6
6 29 0 0 1 83 6
7 29 1 0.03 0.97 80 6
12 28 0 0 1 80 6
18 24 0 0 1 80 6
30 21 1 0.05 0.95 76 7
42 18 0 0 1 76 7
48 13 1 0.08 0.92 70 9
54 11 0 0 1 70 9
55 11 1 0.09 0.91 64 10
60 9 0 0 1 64 10
62 8 0 0 1 64 10
84 6 0 0 1 64 10
96 5 0 0 1 64 10
108 5 0 0 1 64 10
120 3 0 0 1 64 10
180 3 0 0 1 64 10
204 1 0 0 1 64 10
